John Northcott
Corporate Officer/Principal chez ARVINAS, INC.
Profil
John Northcott is currently the Chief Commercial Officer at Arvinas, Inc. Prior to this, he was the Chief Commercial Officer & Senior Vice President at Nektar Therapeutics from 2019 to 2022, the Chief Commercial Officer at Pharmacyclics LLC from 2015 to 2019, and the VP-Marketing, Commercial Strategy & Operations at Lexicon Pharmaceuticals, Inc. from 2013 to 2015.
Mr. Northcott received his undergraduate degree from St. Francis Xavier University.
Postes actifs de John Northcott
Sociétés | Poste | Début |
---|---|---|
ARVINAS, INC. | Corporate Officer/Principal | 01/08/2022 |
Anciens postes connus de John Northcott
Sociétés | Poste | Fin |
---|---|---|
NEKTAR THERAPEUTICS | Corporate Officer/Principal | 30/06/2022 |
PHARMACYCLICS, INC. | Corporate Officer/Principal | 01/01/2019 |
LEXICON PHARMACEUTICALS, INC. | Chief Operating Officer | 01/12/2015 |
Formation de John Northcott
St. Francis Xavier University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
NEKTAR THERAPEUTICS | Health Technology |
LEXICON PHARMACEUTICALS, INC. | Health Technology |
ARVINAS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Pharmacyclics LLC
Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |